Former WuXi Biologics Chief Technology Officer Zhou Weichang joins Yilian Biologics
On July 1st, Yilian Biologics announced the official appointment of Dr. Zhou Weichang as the company's Chief Technology Officer. The company stated that Dr. Zhou's extensive industry experience in biomedicine will help Yilian Biologics strengthen the global development process of its innovation pipeline. Previously, Dr. Zhou held important positions such as Executive Director, Chief Technology Officer, and Global Biologics Development and Operations President at WuXi Biologics. Before joining WuXi Biologics in 2012, he held senior leadership positions in the CMC teams at well-known institutions such as Genzyme Corporation, PDL BioPharma Inc., and Merck & Co. Inc
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments